Dynamic and Adaptive Engagement
Our core technology is built upon our fundamental understanding of the role that protein folding and the motion of molecules play in giving rise to dynamic conformational diversity, where an amino acid sequence can adopt multiple structures and functions. Adagene has created a platform composed of unique, multi-purpose, antibody technologies and a growing pipeline of leading assets with novel MOAs.
Life is motion. The motion of proteins and their dynamic interactions trigger a cascade of complex biological and pharmacological effects.
Our Dynamic, Multi-Purpose Discovery Engine
Empowered by precision engineering, Adagene identifies and selects antibody candidates that are most likely to achieve the desired biological effects.
News & Events
2021.06.16 | Adagene Announces Inclusion in FTSE Russell Indexes
2021.05.26 | Adagene to Present at Upcoming Investor Conferences
Goldman Sachs 42nd Annual Global Healthcare Conference
Thursday, June 10, 2021 at 5:30 PM ET
Click here for webcast